Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 2, 2019PLoS ONEOpen Access

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDavid Jungpa LeeNKNagalingeswaran KumarasamySRStephen Resch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lee et al. (2019) studied this question.

synapsesocial.com/papers/6a997e4df2118addfb54c212https://doi.org/10.1371/journal.pone.0218890
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Scaling up Xpert MTB/RIF technology: the costs of laboratory‐ <i>vs.</i> clinic‐based roll‐out in South Africa2012 · 54 citations
  2. 2Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples2013 · 138 citations
  3. 3Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis2017 · 73 citations
  4. 4Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India2015 · 97 citations
  5. 5Rapid Diagnosis of Mycobacterium tuberculosis with Truenat MTB: A Near-Care Approach2013 · 123 citations